Esophageal Squamous Cell Carcinoma Clinical Trials in Nanjing, Jiangsu
5 recruitingNanjing, Jiangsu, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Jiangsu Cancer Institute & Hospital22 enrolled1 locationNCT07435454
Recruiting
Phase 2
A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Neoadjuvant TherapyLocally Advanced Esophageal Squamous Cell Carcinoma
Sun Jing30 enrolled1 locationNCT06356688
Recruiting
Phase 3
Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University40 enrolled1 locationNCT06563869
Recruiting
Not Applicable
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
Esophageal Squamous Cell CarcinomaChemotherapy EffectSide Effect of Drug
The First Affiliated Hospital with Nanjing Medical University1,216 enrolled1 locationNCT05775419
Recruiting
Not Applicable
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
Esophageal Squamous Cell CarcinomaChemoradiotherapySurvival
Fudan University320 enrolled3 locationsNCT04519905